Atrial Fibrillation, Stroke
Conditions
Interventions
None listed
Sponsors
Keio University School of Medicine, Department of Cardiology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients with diagnosis of atrial fibrillation patients (diagnosed or referred within 6 months).
Exclusion criteria
Exclusion criteria: 1. Patients who were not able to give consent 2. Younger than 20 years old 3. Patients who are considered inappropriate to participate in the study by the treating physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Death (all-cause death, cardiovascular death, non-cardiovascular death) 2. Stroke (ischemic, hemorrhagic, unknown) 3. Systemic embolism 4. Major bleeding, non-major bleeding with specific healthcare provider responses 5. Major adverse cardiovascular event (acute myocardial infarction, unstable angina, undergoing percutaneous coronary intervention, heart failure) | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality-of-life measured by the Atrial Fibrillation Effect on QualiTy-of-Life Questionnaire (AFEQT) | — |
Countries
Japan
Contacts
Public ContactNobuhiro Ikemura
Keio University School of Medicine Department of Cardiology
Outcome results
None listed